Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Polygenic risk score, psychosocial environment and the risk of attention-deficit/hyperactivity disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Daily estimates of clinical severity of symptoms in bipolar disorder from smartphone-based self-assessments

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Genetic stratification of depression in UK Biobank

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Daily mobility patterns in patients with bipolar disorder and healthy individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The impact of the trajectory of bipolar disorder on global cognitive function: A one-year clinical prospective case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Bipolar disorders

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Bipolar disorder (BD) is a mental disorder characterized by recurrent relapses of affective episodes, cognitive impairment, illness progression, and reduced life expectancy. Increased systemic oxidatively generated nucleoside damage have been found in some neurodegenerative disorders and in BD. As the first, this naturalistic prospective, longitudinal follow-up case-control study investigated cerebrospinal fluid (CSF) oxidative stress markers 8-oxo-7,8-dihydroguanosine (8-oxoGuo) and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) that relate to RNA and DNA damage, respectively. Patients with BD (n = 86, 51% female) and gender-and-age-matched healthy control individuals (HC; n = 44, 44% female) were evaluated at baseline (T0), during (T1) and after a new affective episode (T2), if it occurred, and after a year (T3). Cerebrospinal and urine oxidative stress markers were analyzed using ultra-performance liquid chromatography-tandem mass spectrometry. CSF-8-oxoGuo was statistically significantly higher by 18% (p = 0.003) in BD versus HC at T0, and by 22% (p = 0) at T3. CSF-8-oxoGuo had increased by 15% (p = 0.042) from T0 to T3, and by 14% (p = 0.021) from T2 to T3 in patients, who experienced an episode during follow-up. CSF-8-oxodG had increased by 26% (p = 0.054) from T0 to T2 and decreased by 19% (p = 0.041) from T2 to T3 in patients, who experienced an episode during follow-up. CSF-8-oxoGuo did not show a statistically significant change in HC during the one-year follow-up. CSF and urine-8-oxoGuo levels correlated moderately. In conclusion, CSF oxidative stress marker of RNA damage 8-oxoGuo showed both state and trait dependence in BD and stability in HC. Central RNA damage may be a potential biomarker for BD.

OriginalsprogEngelsk
Artikelnummer325
TidsskriftTranslational psychiatry
Vol/bind9
Udgave nummer1
Sider (fra-til)325
ISSN2158-3188
DOI
StatusUdgivet - 1 dec. 2019

ID: 58485480